← All indications
HIV Infections
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Subtype terms (11)
More specific conditions that are subtypes of HIV Infections in the MeSH hierarchy.
- Acquired Immunodeficiency Syndrome
138 drugs (80 approved, 58 experimental)
- Acute Retroviral Syndrome
- AIDS Arteritis, Central Nervous System
- AIDS-Associated Nephropathy
5 drugs approved
- AIDS Dementia Complex
21 drugs (16 approved, 5 experimental)
- AIDS-Related Complex
3 drugs approved
- AIDS-Related Opportunistic Infections
8 drugs approved
- HIV-Associated Lipodystrophy Syndrome
31 drugs (28 approved, 3 experimental)
- HIV Enteropathy
1 drug approved
- HIV Seropositivity
31 drugs (21 approved, 10 experimental)
- HIV Wasting Syndrome
8 drugs (7 approved, 1 experimental)
Drugs by status
Approved for this indication (43)
- darunavir
- nelfinavir
- zidovudine
- lopinavir
- elvitegravir
- cobicistat
- etravirine
- ganciclovir
- ibalizumab-uiyk
- tenofovir
- fosamprenavir
- efavirenz
- tenofovir alafenamide
- bictegravir
- zalcitabine
- amprenavir
- didanosine
- doravirine
- ritonavir
- raltegravir
- emtricitabine
- dolutegravir
- enfuvirtide
- isoniazid
- tipranavir
- lenacapavir
- delavirdine
- fostemsavir
- atazanavir
- rilpivirine
- +13 more
Phase 4 trials (157)
- diflunisal
- mupirocin
- ofloxacin
- temazepam
- inactivated influenza vaccine
- valaciclovir
- fluconazole
- simeprevir
- cycloserine
- pyrimethamine
- pneumococcal 13-valent conjugate vaccine
- adenosma glutinosum
- spironolactone
- protionamide
- rivastigmine
- proguanil
- ezetimibe
- procaine benzylpenicillin
- aciclovir
- ibandronate
- pretomanid
- norgestrel
- armodafinil
- eclipta prostrata
- midazolam
- trimethoprim
- impatiens balsamina
- sulforaphane
- modafinil
- zoledronic acid
- +127 more
Phase 3 trials (118)
- bempedoic acid
- Oglufanide
- codeine
- imiquimod
- erythromycin
- glucose
- amino acids
- gentian violet
- high-selenium yeast
- ub-421
- primaquine
- nitazoxanide
- evolocumab
- alirocumab
- clindamycin
- kallunk oxide
- gs-1720
- itraconazole
- leucovorin
- bivalent subtype c gp120
- valsartan
- berberine
- sorivudine
- vcp1521
- posaconazole
- adefovir dipivoxil
- zinc
- tesamorelin
- ampicillin
- methylprednisolone
- +88 more
Phase 2 trials (343)
- mva-mbn32
- thv01-2
- lc002
- dna-c
- nivolumab
- thymus humoral factor
- dna-hiv-pt123
- syngem
- ren-1654
- romiplostim
- fomivirsen sodium
- capecitabine
- gsk364735
- formaldehyde
- ro 24-7429
- vaccine against cd4 reactive t cells
- measles, mumps, and rubella vaccine
- beclomethasone
- sb-728mr-t
- carmustine
- semaglutide
- pomalidomide
- interleukin-12
- procysteine
- baricitinib
- recombinant soluble human cd4
- dna.hiva
- mifepristone
- thalidomide
- recombinant hiv-1 tat protein
- +313 more
Phase 1 trials (359)
- fluorodopa
- diethylhomospermine
- vrc rad5 vaccine
- vh4527079
- lactobacillus jensenii
- diltiazem
- vir-1111
- vcp65
- prostaglandin
- hypericin
- hiv-specific cd8 cells
- opc 14117
- polyenv1
- nyvac-hiv-pt4
- gla-af
- dna-c2
- cpt31
- erlotinib
- bryostatin
- l-histidine
- peldesine
- hiv p17/p24:ty-vlp
- mk-4250
- gw 695634
- hb-501
- vrc01.23ls
- cpg 1018
- hiv dna vaccine
- interleukin-4
- envpro
- +329 more
Other trials (75)
- amodiaquine
- potassium
- rimabotulinumtoxinB
- sodium phosphate
- a5058s
- hexachlorophene
- sidarbenamide
- vitamin c
- auranofin
- glycolic acid
- guar gum
- bacitracin
- calcitriol
- proalgazyme
- pomegranate
- amoxicillin
- Lactobacillus acidophilus
- lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
- soybean
- autologous seminal fluid
- dc vaccine
- allogeneic dendritic cells
- d&c green no. 5
- olbetam
- diphenhydramine
- artesunate
- cimetidine
- methoxsalen
- haemophilus influenzae type b conjugate vaccine
- moringa oleifera
- +45 more
Organizations
Organization Involved with Phase 4 Indications (222)
- Bausch Health Companies
- Hospital General Universitario Gregorio Marañon
- Fenway Community Health
- National Institute of Mental Health (NIMH)
- Pierre and Marie Curie University
- University of Minnesota
- Puerto Rico Community Network for Clinical Research on AIDS
- Hospital Universitario Ramon y Cajal
- The HIV Netherlands Australia Thailand Research Collaboration
- Hospital Federal dos Servidores do Estado
- OLVG hospital, Amsterdam
- Brown University
- University of California, Riverside
- French Development Agency
- Government of Spain
- Novo Nordisk
- French National Agency for Research on AIDS and Viral Hepatitis
- Community Research Initiative of New England
- Helios Salud, Buenos Aires, Argentina
- Baylor University
- Pronova BioPharma
- International Antiviral Therapy Evaluation Center (IATEC)
- Kennemer Gasthuis
- University of Arizona
- Yeshiva University
- East Carolina University
- University of Geneva
- Clinique du Quartier Latin
- University of Malaya
- CIHR Canadian HIV Trials Network
- +192 more
Organization Involved with Phase 3 Indications (171)
- University of Natal
- University of Hawaii
- Isala Clinics, Zwolle, The Netherlands
- Chipscreen Biosciences, Ltd.
- University of Nairobi
- Amgen
- CHU Fann Dakar
- Government of France
- University of York
- Hospital de Granollers
- University of Alabama, Birmingham
- University of Twente
- University of Guadalajara
- PENTA Foundation
- Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
- Perinatal HIV Research Unit, Baragwanath
- Triangle Pharmaceuticals
- University of Oxford
- Takeda
- Sanofi-Aventis
- Hospital Universitari Son Dureta
- Free University of Brussels
- Vaccine and Gene Therapy Institute, Florida
- VaxGen
- Indian Council of Medical Research
- University of Nantes
- Government of Luxembourg
- New York University
- Centre Hospitalier de Tourcoing
- Northwestern University
- +141 more
Organization Involved with Phase 2 Indications (202)
- Stony Brook University
- Centaur Pharmaceuticals
- Aurum Health Research Limited
- Genelabs Technologies
- Ganeden Biotech, Inc.
- University of Arkansas
- Conant Medical Clinical Research
- University of Burgundy
- University of California, Irvine
- Ajinomoto
- University of Malawi
- EDCTP
- Washington University in St. Louis
- Kilimanjaro Christian Medical College, Tanzania
- Hektoen Institute for Medical Research
- Adult AIDS Clinical Trials Group
- PHPT Foundation
- KwaZulu-Natal
- AmpliPhi Biosciences Corporation
- Solvay
- Autonomous University of Madrid
- University of Kwa-Zulu Natal
- Siriraj Hospital
- Italian Ministry of Foreign Affairs - General Direction for Cooperation and Development
- University of Melbourne
- CR2O
- Los Angeles LGBT Center
- International AIDS Vaccine Initiative
- Achillion Pharmaceuticals
- Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
- +172 more
Organization Involved with Phase 1 Indications (122)
- LXR Biotechnology
- Medicines Development for Global Health
- Procept
- Anthony Mills, MD, Inc.
- Ghent University
- Steinhart Medical Associates
- National Center for Infectious Diseases
- Sun Yat-Sen University
- Kanglin Biotech (Hangzhou) Co. LTD
- Oak Crest Institute of Science
- Harbor Therapeutics
- US Biotest
- Dynavax Technologies Corporation
- Profectus BioSciences, Inc.
- Chiang Rai District Health Office
- Bugando Medical Centre
- MRA Clinical Research
- Jacobus Pharmaceutical
- National Center for HIV STD and TB Prevention
- Parke-Davis
- Beijing Medical University
- University of Copenhagen
- Argus Pharmaceuticals
- Advanced Biotherapy, Inc.
- Guangzhou Medical University
- Genzyme
- Ashodaya Samithi
- Impact Clinical Trials
- Hospital Italiano de Buenos Aires
- National Institute for Health Research, United Kingdom
- +92 more
Organization Involved with Other Experimental Indications (58)
- MACC Fund Research Center
- University of Roma La Sapienza
- University of Antwerp
- The AIDS Foundation, Denmark
- Guilin Medical University
- Northern California Institute of Research and Education
- The Swedish Research Council
- Kenya Ministry of Health
- Moorgreen Hospital, Southampton
- Y. R. Gaitonde Centre for AIDS Research and Education
- American Heart Association
- Gathe, Joseph, M.D.
- Réseau Africain de Recherche sur le SIDA
- Newport Pharmaceuticals International
- Heifer Project International
- China Academy of Chinese Medical Sciences
- Universidade Federal do Rio Grande do Norte
- University of Cambridge
- Africa Centre For Health and Population Studies, South Africa
- Danish Council for Development Research
- Centers for Medicare and Medicaid Services
- Warner Lambert
- Mills Clinical Research
- Mbarara University of Science and Technology
- Catholic University of Health and Allied Sciences
- National Center for Global Health and Medicine
- University of Vienna
- Daiwa Pharmaceutical Corporation
- Yonsei University
- Moi Univeristy
- +28 more